Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria

NCT01977820 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment challenges

Conditions

Phenylketonuria

Interventions

DRUG: Sapropterin
DRUG: Placebo

Sponsor

BioMarin Pharmaceutical